GRAIL Inc (GRAL) Short-Term Debt to Equity

Graphic logo of grail.com (GRAL)

GRAIL, Inc. (GRAL) attracts leading geneticists and bioinformaticians through its ambitious goals in the fight against oncology. Through partnerships with clinics and insurers, the company is implementing multi-cancer Galleri tests. This trading chart captures the indicator at 0.01, linking operational successes to market value. The uniqueness of the early blood-based diagnostic method provides the issuer with colossal pricing power.

GRAL - GRAIL Inc Short-Term Debt to Equity Ratio over the range 06/29/2024 - 10/29/2026

Financial and market metric breakdowns for grail.com (GRAL)

- stock quotes and analyst forecast:
Stock Price GRAIL Corp|GRAL - Analyst Consensus Forecast
- market capitalization details:
Market Value GRAIL Inc|GRAL - Business Value
- balance sheet equity data:
Book Value per Share GRAIL|GRAL - Company Net Assets|Market Capitalization to Book Value Ratio grail.com|GRAL - Company Assets
- business debt structure and liquidity details:
Debt to Equity GRAIL, Inc.|GRAL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio GRAIL|GRAL - Aggregate Debt Obligations|Debts to Book Capitalization GRAIL Inc|GRAL - Company Long-Term Debts|Company Short-Term Debt GRAIL|Quick Ratio grail.com
- earnings and market ratios statistics:
GRAL - Net Profit
Fundamental valuation:GRAIL Corp
Signature product of GRAIL Inc

For GRAIL, Inc., which possesses exceptional market influence due to innovative cancer diagnostics, the short-term debt-to-equity history reflects the efficiency of liquidity management during a period of expansion. This ratio compares liabilities due within one year to net assets, where an increase in value signals a risk of capital deficiency as borrowing costs rise, while a decrease confirms the financial stability of the balance sheet.

Analysis of competing companies

Short-Term Debt to Capital CAI|Short-Term Debt to Capital Guardant Corp (GH)|Short-Term Debt to Equity Veracyte, Inc. VCYT|CELC: Short-Term Debt to Capital Ratio|Myriad Genetics - Short-Term Debt to Capital|Castle Biosciences Inc (CSTL) - Short-Term Debt to Equity Ratio|BNR: Short-Term Debt to Capital|Current Liabilities to Capital VolitionRx (VNRX)|Short-Term Debt to Equity Biodesix, Inc.|PRPO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio CHEK (Check-Cap Ltd.)|MYNZ (mainzbiomed.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital OCX (OncoCyte Corp.)